Viewing Study NCT06524635

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:37 PM
Ignite Modification Date: 2026-06-25 @ 1:47 AM
Study NCT ID: NCT06524635
Status: RECRUITING
Last Update Posted: 2025-01-24
First Post: 2024-07-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hidradenitis Suppurativa View
None Atopic Dermatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hidradenitis Suppurativa (HS) View
None Atopic Dermatitis (AD) View
None Lutikizumab View
None ABT-981 View